Paul Mampilly is a well-established American investor who has a key interest in investments, finances. Paul founded Profits Unlimited, a successful investment newsletter with a broad reach of over 90,000 subscribers.
Through Profits Unlimited, Mampilly has helped many individuals make wise investment decisions and has been featured on various news channels like Bloomberg TV, CNBC and Fox Business News. Apart from that he also founded another popular newsletter known as Extreme Fortunes.
Paul Mampilly Career Background
In 1991, Paul kick started his profession at Bankers Trust as an assistant portfolio manager. Within no time, he had progressed and earned high up titles at ING, Royal Bank of Scotland, as well as Deutsche Bank where he was in charge of accounts worth multimillion-dollars. In 2006, Paul was recruited by the owners of Kinetic Asset Management, a 6 billion dollar firm to manage their hedge fund. As a result, the assets of the company rose to 25 billion dollars under the leadership of Mr. Mampilly.
Over the years, Paul has had made wise investment choices based on current market research and trends. In 2012, Mr. Mampilly experienced a 2,500% gain through the investment of a drug treatment developed by Sarepta Therapeutics. In 2016, Paul Mampilly entered into the Banyan Hill Publishing company as a senior editor who specializes in helping Americans find wealth in technology, growth investing and small-cap stocks. Within the same year, Paul also opened a demonstration account with 5000 dollars of money and his stock realized over 180 percent.
Paul had the opportunity to be invited by the Templeton Foundation to participate in the prestigious investment competition. During the 2008 and 2009 financial crisis, he generated a return of 88 million dollars with a starting investment of 50 million dollars. According to Paul, amazing opportunities are around the corner for food companies. In addition, he is also of the opinion and highly recommends that investors should also consider the electric vehicles and precision medical industries. Paul Mampilly believes that using the genomes or genetic information of patients and medical history can help doctors in diagnosing conditions. Paul Mampilly specializes in the finance sector and holds an MBA from Fordham University.